When did Cumberland Pharmaceuticals report Q2 2025 earnings?

Cumberland Pharmaceuticals (CPIX) reported Q2 2025 earnings on August 5, 2025 after market close.

What were Cumberland Pharmaceuticals's Q2 2025 revenue and EPS?

Cumberland Pharmaceuticals reported revenue of $10.8M and eps of $0.02 for Q2 2025.

How did Cumberland Pharmaceuticals's Q2 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 10.0% from $9.8M a year earlier and eps grew 100.0% from $0.01.

Where can I find Cumberland Pharmaceuticals's Q2 2025 SEC filings?

You can read the 10-Q periodic report (0001628280-25-039326) directly on SEC EDGAR. The filing index links above go to sec.gov.

Cumberland Pharmaceuticals CPIX Q2 2025 earnings

Reported August 5, 2025 · After market close

Revenue$10.8M

EPS$0.02

Next report

Aug 4, 2026 (In 6 days)

Revenue estimate$8.5M

EPS estimate-$0.13

Financials

Q2 2025

Income statement

See full

Revenue$10.8M+10.0%

Gross profit$8.8M+8.5%

Operating income-$747.5K+27.2%

Net income-$740.7K+31.8%

EPS (diluted)-$0.05+37.5%

Balance sheet

See full

Cash & equivalents$16.1M-7.2%

Total debt$5.1M-6.9%

Total equity$28.0M+6.2%

Total assets$67.9M-13.5%

Cash flow

See full

Operating cash flow$843.8K+199%

CapEx$26.5K+269%

Free cash flow$817.3K+195%

Valuation & ratios

Valuation

as of 06/30/25

See full

Market cap$49.37M+129%

Enterprise value$38.38M+295%

P/S1.2×+0.6×

Profitability

See full

Gross margin84%+1.4pp

Operating margin-7.1%-3.1pp

Net margin-7%-3.0pp

Returns & leverage

See full

Return on equity-10.8%-4.3pp

Debt / equity0.2×0.0×

Current ratio1.3×-0.1×

Segments

By product

See full

Sancuso$3.1M+42.5%

Vibativ$2.7M+10.1%

Other revenue$492.4K+130%

By geography

See full

Non-US$1.2M+81.5%

Versus estimates

Revenue

Q1 2026$9.1MBeat by $628.3K Q4 2025$13.7MBeat by $5.2M Q3 2025$8.3M

Q2 2025$10.8M

Q1 2025$11.7M Q4 2024$10.4M

Diluted EPS

Q1 2026-$0.13In line Q4 2025-$0.01Beat by $0.12 Q3 2025-$0.06

Q2 2025$0.02

Q1 2025$0.16 Q4 2024-$0.02

Ask the moment Cumberland Pharmaceuticals reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Cumberland Pharmaceuticals report Q2 2025 earnings?: Cumberland Pharmaceuticals (CPIX) reported Q2 2025 earnings on August 5, 2025 after market close.
What were Cumberland Pharmaceuticals's Q2 2025 revenue and EPS?: Cumberland Pharmaceuticals reported revenue of $10.8M and eps of $0.02 for Q2 2025.
How did Cumberland Pharmaceuticals's Q2 2025 results compare year-over-year?: Compared to the same quarter a year prior, revenue grew 10.0% from $9.8M a year earlier and eps grew 100.0% from $0.01.
Where can I find Cumberland Pharmaceuticals's Q2 2025 SEC filings?: You can read the 10-Q periodic report (0001628280-25-039326) directly on SEC EDGAR. The filing index links above go to sec.gov.